Menu

Infographic: Repurposing Strategies

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

Dec 31, 2016
Anna Azvolinsky

 

Types of patents in the U.S.

PATENT VERSUS EXCLUSIVITY

Patents: Granted by the US Patent and Trademark Office (or an analogous agency in another country). Patents generally last for 20 years.

Exclusivity: Granted by the FDA upon drug approval. Exclusive marketing rights, which
range from six months to seven years, give a manufacturer sole promotion rights of a drug for a certain indication as an incentive for drug innovation and prevention of generic drug competition.

Off-label drug use: When a drug is used in a different disease, administered in a different
way or at a different dose than what has been specified in the drug’s label (based on clinical trial data reviewed by the FDA for approval). Any drug on the market can be prescribed on an off-label basis at doctors’ discretion.

Read the full story.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening